🐦 推特Wall St EngineCodex · 实盘不做把握 6/10
北京时间·🕒 发布 18:08:55时区推断·⟳ 抓取 18:09:23·⚡ 决策 07-16 18:11:54 +2m31s·103.1 天前
联合健康二季度业绩大幅超预期并上调全年指引，但盘前股价反向下跌
联合健康（UNH.US）Q2 调整后 EPS 和全年指引均显著高于一致预期，基本面读数本身偏正面。
📄 原文Wall St Engine@wallstengine↗ 原文
UNITEDHEALTH GROUP $UNH Q2’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $112.0B (Est. $110.8B) 🟢; flat YoY 🔹 Adj. EPS: $6.38 (Est.…
不做 联合健康（UNH.US）
财报数字本身利好，但UNH.US为超大市值财报交易，盘前真实价格反向下跌且同业好财报后被卖出；当前缺少正向承接，不做追多，也不满足强空催化开空。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
消息传播链
- 公司投资者关系页列示7月16日Q2财报电话会，说明该财报为盘前正式财报日事件。
- 主流财经媒体报道UNH二季度业绩显著超预期并上调全年盈利预测。
- 2026-07-16 10:10 UTC市场反应stock_quote非一手盘前/最新价418.26美元，低于前收425.325美元约1.66%，好财报未获得即时正向价格确认。市场反应:UNH.US -1.66%
关键理由
- 联合健康（UNH.US）Q2 调整后 EPS 和全年指引均显著高于一致预期，基本面读数本身偏正面。
- 但这是美股超大市值财报事件，盘前真实报价反而较前收下跌约1.66%，说明市场没有把这份好于预期的财报作为立即追多信号。
- 医保成本、会员规模、政府医保业务监管和同业财报后杀跌仍是管理式医疗板块的短线压制。
主要风险
- 若8:00 ET电话会进一步确认医疗成本改善和回购加速，开盘后可能重新转强，当前不做可能错过反转。
- 若雇主险成本、Medicaid/Medicare Advantage会员流失或监管问题被市场放大，财报利好可能继续被卖出。
反向证据
- 做多前查反向 · 来源 web · 日期 2026-07-16 · 影响 weakens
反向证据集中在雇主险成本、政府医保会员流失和Optum收入下滑等问题，削弱追多财报利好的胜率。
检索:UnitedHealth 2026 analyst concerns medical care ratio Optum revenue decline Q2 earnings 原文 ↗ - 做多前查反向 · 来源 web · 日期 2025-07-24 · 影响 weakens
公司此前确认配合司法部对Medicare相关业务的刑事和民事调查，监管尾部风险仍未完全消除。
检索:UnitedHealth DOJ investigation Medicare Advantage 2026 news UNH risk 原文 ↗
工具调用 · 历史记录,结果未知(1 种)
- stock_quote · 结果未知
原文全文
展开原文 · 1,306 字
UNITEDHEALTH GROUP $UNH Q2’26 EARNINGS HIGHLIGHTS
🔹 Revenue: $112.0B (Est. $110.8B) 🟢; flat YoY
🔹 Adj. EPS: $6.38 (Est. $4.85) 🟢; +56% YoY
🔹 Medical Care Ratio (MCR): 86.7% (Est. 88.6%) 🟢; -270 bps YoY
🔹 UnitedHealthcare Op Income: $3.9B; +86% YoY (Est. +40.7% YoY) 🟢
Raises FY26 Guide:
🔹 Adj. EPS: $19.50-$20.00 (Est ~$18.32) 🟢
🔹 EPS: $18.45-$18.95 (Prior: >$17.10)
🔹 Operating Earnings: >$25.45B (Prior: >$24.0B)
🔹 Net Earnings: >$16.75B (Prior: >$15.60B)
🔹 UnitedHealthcare Op. Earnings: >$12.0B (Prior: >$10.8B)
🔹 Optum Op. Earnings: >$13.45B (Prior: >$13.2B)
🔹 Medical Care Ratio: 88.1% ±25 bps (Prior: 88.8% ±50 bps)
🔹 Operating Cash Flow: ~$24.0B (Prior: >$18.0B)
🔹 Share Repurchases: ≥$5.0B (Prior: ~$2.5B)
Segment Net Revenue:
🔹 UnitedHealthcare: $86.0B; flat YoY
🔹 Optum: $65.7B; -2% YoY
Other Q2 Metrics:
🔹 Optum Op Income: $4.0B; +29% YoY (Est. +7.8% YoY) 🟢
🔹 Earnings from Operations: $8.0B; +54% YoY
🔹 Operating Cost Ratio: 12.7%; +40 bps YoY
🔹 Net Margin: 4.9%; +180 bps YoY
🔹 Cash Flows from Operations: $11.1B
Comments:
🔸 “Our results and outlook reflect the continuing progress in our work to simplify how we operate, improve both affordability and the health care experience for patients and care providers and apply modern technology to create real improvement for people.”
🔹 Revenue: $112.0B (Est. $110.8B) 🟢; flat YoY
🔹 Adj. EPS: $6.38 (Est. $4.85) 🟢; +56% YoY
🔹 Medical Care Ratio (MCR): 86.7% (Est. 88.6%) 🟢; -270 bps YoY
🔹 UnitedHealthcare Op Income: $3.9B; +86% YoY (Est. +40.7% YoY) 🟢
Raises FY26 Guide:
🔹 Adj. EPS: $19.50-$20.00 (Est ~$18.32) 🟢
🔹 EPS: $18.45-$18.95 (Prior: >$17.10)
🔹 Operating Earnings: >$25.45B (Prior: >$24.0B)
🔹 Net Earnings: >$16.75B (Prior: >$15.60B)
🔹 UnitedHealthcare Op. Earnings: >$12.0B (Prior: >$10.8B)
🔹 Optum Op. Earnings: >$13.45B (Prior: >$13.2B)
🔹 Medical Care Ratio: 88.1% ±25 bps (Prior: 88.8% ±50 bps)
🔹 Operating Cash Flow: ~$24.0B (Prior: >$18.0B)
🔹 Share Repurchases: ≥$5.0B (Prior: ~$2.5B)
Segment Net Revenue:
🔹 UnitedHealthcare: $86.0B; flat YoY
🔹 Optum: $65.7B; -2% YoY
Other Q2 Metrics:
🔹 Optum Op Income: $4.0B; +29% YoY (Est. +7.8% YoY) 🟢
🔹 Earnings from Operations: $8.0B; +54% YoY
🔹 Operating Cost Ratio: 12.7%; +40 bps YoY
🔹 Net Margin: 4.9%; +180 bps YoY
🔹 Cash Flows from Operations: $11.1B
Comments:
🔸 “Our results and outlook reflect the continuing progress in our work to simplify how we operate, improve both affordability and the health care experience for patients and care providers and apply modern technology to create real improvement for people.”
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。